Taxifolin, scientifically recognized as Dihydroquercetin (DHQ), is rapidly emerging as the gold standard in the "Clean Label" liver protection market. Extracted primarily from the Siberian Larch (Larix sibirica) and Chinese Larch, this bioflavonoid offers a unique molecular structure that provides superior antioxidant capacity compared to traditional quercetin.
In the current global health climate, the "Silent Epidemic" of Non-Alcoholic Fatty Liver Disease (NAFLD) and the rising demand for metabolic health solutions have propelled Taxifolin into the spotlight. As top-tier OEM Liver Protection Taxifolin manufacturers, we are witnessing a 40% year-on-year increase in procurement requests from North America and the EU, driven by clinical studies showcasing Taxifolin’s ability to inhibit lipid peroxidation and modulate inflammatory cytokines within hepatocytes.
The global DHQ market is projected to reach USD 750 million by 2030, with liver support supplements taking the lion's share of the growth.
Over 500 published peer-reviewed studies highlight Taxifolin’s role in capillary stabilization and liver tissue regeneration.
FDA GRAS status and EFSA Novel Food approvals have paved the way for massive industrial adoption in functional beverages.
Established in 2018, Shaanxi Bieyouth Biotech Co., Ltd. has evolved into a powerhouse for plant and animal extracts. As a large-scale gold supplier, we integrate R&D, production, and global sales, specializing in pharmaceutical-grade raw materials and cosmetic actives.
Our facility operates under strict GMP certifications, housing two standardized workshops equipped with world-class supercritical extraction and vacuum low-temperature concentration technology. We are not just a factory; we are an innovation partner for brands in the USA, UK, Canada, and Australia.
Research Breakthroughs
QC Levels
Capacity Leap
Annual Tons
The "China Efficiency" in the Taxifolin sector is rooted in three pillars: Raw Material Proximity, Scale Economy, and Technological Iteration. China's northern larch forests provide a sustainable and cost-effective source of raw biomass. Unlike European counterparts, Shaanxi-based factories like Bieyouth Biotech utilize integrated supply chains that reduce the time from forest to refined powder to less than 72 hours.
Moreover, our factories have moved beyond basic ethanol extraction. We employ High-Performance Liquid Chromatography (HPLC) for real-time purity monitoring, ensuring that every batch of OEM Liver Protection Taxifolin meets a 98% purity threshold. This precision, combined with lower overhead costs, allows global brands to achieve better ROI without compromising on E-E-A-T standards required by modern consumers.
Ideal for capsules targeting ALT/AST enzyme balance and reducing liver steatosis in sedentary populations.
Incorporating water-soluble Taxifolin into "Hangover Recovery" shots to accelerate ethanol metabolism and protect gastric mucosa.
Leveraging DHQ's ability to inhibit tyrosinase for "Skin Glow from Within" formulas that link liver health to dermal clarity.
Participation in Shanghai International Cosmetics (PCHi) showcasing Rose-PDRN and Taxifolin blends.
Official FDA Certification obtained, validating our production safety for the US Market.
Launch of Global Institute of Biology to focus on Cosmetic Raw Material Research.
Awarded "Integrity Enterprise" status for quality assurance in export excellence.
Penny
Angel Wang
Monica Li
Margaret Zhang
We typically provide 95% to 98% purity as measured by HPLC, ensuring maximum therapeutic efficacy for liver protection formulations.
Yes, Shaanxi Bieyouth Biotech is GMP certified, and we obtained our US FDA certificate in August 2023, meeting all international safety standards.
Absolutely. We specialize in complex blends, such as combining Taxifolin with other hepatoprotectives like Silymarin or Glutathione, including custom packaging services.
For standard OEM orders, lead time is usually 7-14 days for production, with rapid air-freight options available for the USA, EU, and Australia.
Bieyouth
